update repl case study

Mythos-Biotechnology-Fund · Oct 20, 2020 · 23b4978 · 23b4978
1 parent 061675e
commit 23b4978
Show file tree

Hide file tree

Showing 2 changed files with 3 additions and 2 deletions.
diff --git a/cases.html b/cases.html
@@ -78,10 +78,11 @@ <h1 style="text-align:center">Case 1: $ARAV</h1>
     </p>
     </center>
 
-  <h1 style="text-align:center">Case 2 $???</h1>
+  <h1 style="text-align:center">Case 2: $REPL</h1>
     <center>
+    <p style="width:250px"><button class="button" onclick="window.open('cases/Mythos_case_2_REPL.pdf','_blank')">Replimune Case Study</button></p>
     <p style="width:750px">
-    Under development
+    Replimune is a biotechnology startup developing oncolytic viruses as immunotherapies. These engineered viruses, derived from herpes simplex virus type 1, are designed to activate local and systemic immune response against cancers. Combinations with checkpoint blockade have demonstrated potent tumor response. The company is managed by those who led efforts in developing and commercializing talimogene laherparepvec (T-Vec), the first oncolytic virus approved by the FDA.
     </p>
     </center>
 

diff --git a/cases/Mythos_case_2_REPL.pdf b/cases/Mythos_case_2_REPL.pdf